Skip to main content

Advertisement

Log in

Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients

  • Original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Cardiovascular disease is an important cause of death in patients with end-stage renal disease. Although coronary artery bypass graft (CABG) surgery and drug-eluting stent (DES) implantation have been compared in chronic hemodialysis patients, the results are unclear.

Methods

The study population consisted of chronic hemodialysis patients (dialysis duration >6 months) with coronary artery disease who underwent DES implantation or CABG at the Asan Medical Center (Seoul, Korea) between January 1, 2003, and February 28, 2006. We followed them until December, 2012. The mean follow-up was 50.91 ± 31.86 months for DES patients and 50.63 ± 36.43 months for CABG patients. Primary end points were major adverse cardiac and cerebral events (MACCE). Propensity-score matching was used to reduce selection bias and variable characteristics.

Results

Of 87 chronic hemodialysis patients with coronary artery disease, 44 underwent DES implantation and 43 underwent CABG surgery. Multivessel disease patients were 70.45 % in the DES group and 95.35 % in the CABG group. After propensity score adjustment, the MACCE-free survival was significantly higher in the CABG group than in the DES group (HR 3.265; 95 % CI 1.357–7.858; p = 0.008), but overall survival did not differ between the groups (HR 0.968; 95 % CI 0.267–3.507; p = 0.960).

Conclusion

We found that, compared with DES, CABG showed significantly better MACCE-free survival in chronic hemodialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. National Institues of Health (2000) USRDS 2000 Annual Data Report. National Institutes of Health, Bethesda. pp 589–684

  2. SoS Investigators et al (2002) Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360(9338):965–970

  3. Mercado N, Wijns W, Serruys PW et al (2005) One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130(2):512–519

    Article  PubMed  Google Scholar 

  4. Morrison DA, Sethi G, Sacks J et al (2001) Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 38(1):143–149

    Article  CAS  PubMed  Google Scholar 

  5. Hannan EL, Racz MJ, Walford G et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352(21):2174–2183

    Article  CAS  PubMed  Google Scholar 

  6. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS (2004) Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109(19):2290–2295

    Article  PubMed  Google Scholar 

  7. Hannan EL, Wu C, Walford G et al (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358(4):331–341

    Article  CAS  PubMed  Google Scholar 

  8. Li Y, Zheng Z, Xu B et al (2009) Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Circulation 119(15):2040–2050

    Article  CAS  PubMed  Google Scholar 

  9. Park DW, Yun SC, Lee SW et al (2008) Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117(16):2079–2086

    Article  CAS  PubMed  Google Scholar 

  10. Rodriguez AE, Maree AO, Mieres J et al (2007) Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 28(17):2118–2125

    Article  PubMed  Google Scholar 

  11. Serruys PW, Morice MC, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972

    Article  CAS  PubMed  Google Scholar 

  12. Kappetein AP, Head SJ, Morice MC et al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43(5):1006–1013

    Article  PubMed  Google Scholar 

  13. Manabe S, Shimokawa T, Fukui T et al (2009) Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome? J Card Surg 24(3):234–239

    Article  PubMed  Google Scholar 

  14. Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T (2010) Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 89(6):1896–1900 (discussion 1900)

    Article  PubMed  Google Scholar 

  15. Task Force on Myocardial Revascularization of the European Society of C, the European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555

    Article  Google Scholar 

  16. Lauer MS, Blackstone EH, Young JB, Topol EJ (1999) Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 34(3):618–620

    Article  CAS  PubMed  Google Scholar 

  17. Terazawa S, Tajima K, Takami Y et al (2012) Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients. J Card Surg 27(3):281–287

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Baxter.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung Min Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baek, C.H., Kim, SO., Park, SJ. et al. Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients. J Nephrol 27, 87–93 (2014). https://doi.org/10.1007/s40620-013-0023-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-013-0023-2

Keywords

Navigation